Barclays’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Sell |
1,577
-77
| -5% | -$1.17K | ﹤0.01% | 4067 |
|
|
2025
Q1 | $25K | Buy |
1,654
+709
| +75% | +$10.7K | ﹤0.01% | 4033 |
|
|
2024
Q4 | $12K | Sell |
945
-394
| -29% | -$5K | ﹤0.01% | 4168 |
|
|
2024
Q3 | $19K | Buy |
1,339
+1,337
| +66,850% | +$19K | ﹤0.01% | 4066 |
|
|
2024
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 4314 |
|
|
2024
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 4278 |
|
|
2023
Q4 | $0 | Sell |
2
-1,578
| -100% | – | ﹤0.01% | 4332 |
|
|
2023
Q3 | $24K | Sell |
1,580
-50,256
| -97% | -$763K | ﹤0.01% | 3862 |
|
|
2023
Q2 | $814K | Sell |
51,836
-1,638,505
| -97% | -$25.7M | ﹤0.01% | 2291 |
|
|
2023
Q1 | $27.9M | Buy |
1,690,341
+3,200
| +0.2% | +$52.7K | 0.01% | 510 |
|
|
2022
Q4 | $26.3M | Sell |
1,687,141
-2,900
| -0.2% | -$45.2K | 0.01% | 555 |
|
|
2022
Q3 | $21.9M | Buy |
1,690,041
+3,069
| +0.2% | +$39.8K | 0.02% | 565 |
|
|
2022
Q2 | $23.7M | Hold |
1,686,972
| – | – | 0.01% | 521 |
|
|
2022
Q1 | $24.2M | Buy |
1,686,972
+246,199
| +17% | +$3.53M | 0.02% | 601 |
|
|
2021
Q4 | $19.6M | Sell |
1,440,773
-41,087
| -3% | -$560K | 0.01% | 677 |
|
|
2021
Q3 | $24.3M | Buy |
1,481,860
+433,930
| +41% | +$7.11M | 0.01% | 624 |
|
|
2021
Q2 | $17.6M | Buy |
1,047,930
+465,182
| +80% | +$7.83M | 0.01% | 726 |
|
|
2021
Q1 | $10.6M | Buy |
582,748
+429,929
| +281% | +$7.85M | 0.01% | 818 |
|
|
2020
Q4 | $2.78M | Sell |
152,819
-149,627
| -49% | -$2.72M | ﹤0.01% | 1379 |
|
|
2020
Q3 | $5.4M | Sell |
302,446
-645
| -0.2% | -$11.5K | ﹤0.01% | 937 |
|
|
2020
Q2 | $5.43M | Sell |
303,091
-35,864
| -11% | -$643K | ﹤0.01% | 890 |
|
|
2020
Q1 | $5.15M | Sell |
338,955
-71,157
| -17% | -$1.08M | ﹤0.01% | 857 |
|
|
2019
Q4 | $8.09M | Sell |
410,112
-24,100
| -6% | -$475K | ﹤0.01% | 947 |
|
|
2019
Q3 | $7.47M | Buy |
434,212
+128,577
| +42% | +$2.21M | ﹤0.01% | 906 |
|
|
2019
Q2 | $5.41M | Buy |
305,635
+52,076
| +21% | +$922K | ﹤0.01% | 1057 |
|
|
2019
Q1 | $5.17M | Buy |
253,559
+232,058
| +1,079% | +$4.73M | ﹤0.01% | 969 |
|
|
2018
Q4 | $362K | Buy |
+21,501
| New | +$362K | ﹤0.01% | 2446 |
|